Evelyne Bischof

Corporate Officer/Principal chez InSilico Medicine, Inc.

Profil

Evelyne Bischof MD, MHP, FEFIM, is one of LongeVC's Advisory Board members and the Chairman of the Longevity Science Foundation Visionary Board.
She is also a longevity physician at Human Longevity, Inc., where she works with leading elite executives on their longevity, integrating precision diagnostics of HLI, AI-based monitoring with deep ageing analysis and individualised therapies.
Deeply passionate about next-generation medical technology, she is an expert in internal medicine and oncology, focusing on preventative and precision medicine, biogerontology and geronto-oncology.
Evelyne is enthusiastic about artificial intelligence applications for biomedical research and practice.
Apart from working at Human Longevity, Inc., she is also part of Holmusk, Insilico Medicine, Shanghai Jiao Tong University School of Medicine, and Shanghai University of Medicine and Health Sciences.
She also held positions at University Hospital Basel, Tongji University and University Hospital Zürich.
Evelyne spent a decade practicing medicine and performing translational research in Switzerland, the US and China.
A Harvard- and Columbia-trained physician, Evelyne is the author of more than 40 peer-reviewed papers and is a frequent speaker at scientific and medical conferences.

Postes actifs de Evelyne Bischof

Sociétés	Poste	Début
InSilico Medicine, Inc.	Corporate Officer/Principal	01/12/2019
Human Longevity, Inc.	Corporate Officer/Principal	01/01/2020
LongeVC	Consultant / Advisor	-

Anciens postes connus de Evelyne Bischof

Sociétés	Poste	Fin
Holmusk USA, Inc.	Corporate Officer/Principal	30/04/2022